Financhill
Back

Credit Suisse Asset Management Income Fund Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
40

CIK
Credit Suisse Asset Management Income Fund Inc.

Last Price:
$2.83
Seasonality Move:
2.58%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
40
Credit Suisse Asset Management Income Fund Inc. (CIK) is a Sell

Is Credit Suisse Asset Management Income Fund Inc. a Buy, Sell or Hold?

  • The current Credit Suisse Asset Management Income Fund Inc. [CIK] share price is $2.82. The Score for CIK is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • CIK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CIK Stock Price Chart

What is Credit Suisse Asset Management Income Fund Inc.'s stock price today?

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

CIK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 49.91 Sell
Chaikin Money Flow: -122516 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.79 - 2.83) Buy
Bollinger Bands (100): (2.82 - 2.98) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

CIK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.81 Buy
20-day SMA: 2.82 Buy
50-day SMA: 2.83 Sell
200-day SMA: 2.89 Sell
8-day EMA: 2.81 Buy
20-day EMA: 2.82 Buy
50-day EMA: 2.84 Sell
200-day EMA: 2.89 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Credit Suisse Asset Management Income Fund Inc. Earnings Growth & CIK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Credit Suisse Asset Management Income Fund Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):